Modular Medical (MODD) Liabilities and Shareholders Equity (2021 - 2026)
Modular Medical's (MODD) quarterly Liabilities and Shareholders Equity came in at $12.3 million in Q2 2026, down 13.53% on a YoY basis from $14.2 million in Q2 2025, and down 17.39% quarter-over-quarter from $14.8 million in Q1 2026.
Analysis
Modular Medical (MODD) Liabilities and Shareholders Equity (2021 - 2026) Analysis & Trends
Modular Medical (MODD) has reported Liabilities and Shareholders Equity for 6 consecutive years, with $12.3 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Liabilities and Shareholders Equity fell 13.53% year-over-year to $12.3 million; the trailing twelve-month figure through Jun 2026 stood at $50.3 million (down 6.52% YoY), and the FY2026 full-year result was $14.8 million, down 20.83% from the prior year.
- Liabilities and Shareholders Equity declined to $12.3 million in Q2 2026 per MODD's latest filing, from $14.8 million in the prior quarter.
- Across five years, Liabilities and Shareholders Equity topped out at $18.7 million in Q1 2025 and bottomed at $6.2 million in Q4 2023.
- Historically, Liabilities and Shareholders Equity has averaged $11.6 million across 5 years, with a median of $11.8 million in 2022.
- The sharpest annual moves came in 2022 and 2023: Liabilities and Shareholders Equity soared 1062.33% in 2022, then dropped 29.06% in 2023.
- Over 5 years, Liabilities and Shareholders Equity stood at $8.7 million in 2022, then slipped by 29.06% to $6.2 million in 2023, then jumped by 95.98% to $12.1 million in 2024, then declined by 15.56% to $10.3 million in 2025, then increased by 19.44% to $12.3 million in 2026.
- According to Business Quant data, Liabilities and Shareholders Equity over the past three periods registered $12.3 million, $14.8 million, and $10.3 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn | 109.22 Bn |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn | 20.88 Bn |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn | 93.31 Bn |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn | 47.93 Bn |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn | 45.22 Bn |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn | 13.87 Bn |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn | 31.10 Bn |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | 6.46 Bn |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn | 10.74 Bn |
| 10 | Modular Medical | 15.54 Mn | 11.62 Mn | - | 12.25 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 12.25 Mn |
| Mar 31, 2026 | 14.83 Mn |
| Dec 31, 2025 | 10.26 Mn |
| Sep 30, 2025 | 12.97 Mn |
| Jun 30, 2025 | 14.17 Mn |
| Mar 31, 2025 | 18.74 Mn |
| Dec 31, 2024 | 12.15 Mn |
| Sep 30, 2024 | 8.77 Mn |
| Jun 30, 2024 | 10.07 Mn |
| Mar 31, 2024 | 13.81 Mn |
| Dec 31, 2023 | 6.20 Mn |
| Sep 30, 2023 | 10.06 Mn |
| Jun 30, 2023 | 13.67 Mn |
| Mar 31, 2023 | 7.25 Mn |
| Dec 31, 2022 | 8.74 Mn |
| Sep 30, 2022 | 11.44 Mn |
| Jun 30, 2022 | 14.44 Mn |
| Mar 31, 2022 | 9.85 Mn |
| Dec 31, 2021 | 751,839.00 |
| Sep 30, 2021 | 1.37 Mn |